Clinical Trials Directory

Trials / Unknown

UnknownNCT00000338

Infusion Laboratory: Protocol 2 (Lisuride) - 3

Infusion Laboratory: Protocol 2 (Lisuride)

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
2 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate clinical safety issues pertaining to lisuride, to cocaine, and to its interaction in a chronic, crack dependent population, and to determine how pretreatment with lisuride modifies the subjective as well as physiological effects of cocaine.

Conditions

Interventions

TypeNameDescription
DRUGLisuride

Timeline

Start date
1996-03-01
First posted
1999-09-21
Last updated
2017-01-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000338. Inclusion in this directory is not an endorsement.

Infusion Laboratory: Protocol 2 (Lisuride) - 3 (NCT00000338) · Clinical Trials Directory